Study shows inequities in HDFN care access across Mexico
A recent study showed access to Rh immunoglobulin for pregnancies affected by HDFN in Mexico is unequal across different regions.
A recent study showed access to Rh immunoglobulin for pregnancies affected by HDFN in Mexico is unequal across different regions.
A recent study showed antigen matching before blood transfusion in women under 45 appears to prevent HDFN due to cEK alloimmunization.
A recent case report described a patient with HDFN that was wrongly diagnosed as neonatal alloimmune thrombocytopenia (NAIT).
A novel method for predicting the presence of anti-Jr antibodies in blood could facilitate the diagnosis of Jr-mediated HDFN.
A recent case report described HDFN caused by ABO alloimmunization in which the mother had both anti-Jka and anti-B antibodies.
Alloantibodies against the Rh and Kell appear to be the most prevalent in pregnancies complicated with HDFN, a recent study showed.
A newborn with HDFN due to Rh17 alloimmunization was successfully treated with incompatible blood, according to a recent case report.
Nipocalimab, a monoclonal antibody with a potential role in HDFN prevention, has shown promising results in a study of Japanese volunteers.
A review was recently published highlighting laboratory techniques and challenges in diagnosing alloimmunization and preventing HDFN.
In a recent study, proper prenatal care and HDFN prophylaxis through Rh immunoglobulin (RHIG) prevented complications in Rh-negative patients.